ACE2 and Kallmann syndrome: The importance of ACE2 binding by SARS‐CoV2 in COVID‐19 is underscored by the observation that anosmia and dysgeusia have recently been observed in patients with COVID‐1910 and that ACE2 expression has recently been found to be high in the oropharynx and tongue.11